Navigation Links
Solta Medical Reports First Quarter 2013 Results
Date:5/1/2013

9962,017Remeasurement of contingent consideration liability

(3,100)4,700Acquisition-related expenses

1,39493Severance expenses

31330Stock-based compensation

1,2001,140Non-GAAP income (loss) from operations

$63($388)Depreciation expenses

875938Non-GAAP Adjusted EBITDA

$938$550GAAP net loss($2,595)($8,799)Non-GAAP adjustments to net loss:Amortization and other non-cash acquisition related charges

1,9962,017Remeasurement of contingent consideration liability

(3,100)4,700Acquisition-related expenses

1,39493Severance expenses

31330Stock-based compensation

1,2001,140Non-GAAP net loss

($792)($819)GAAP basic net loss per share

($0.04)($0.14)Non-GAAP adjustments to basic loss per share:Amortization and other non-cash acquisition related charges

$0.03$0.03Remeasurement of contingent consideration liability

($0.04)$0.08Acquisition-related expenses

$0.02$0.00Severance expenses

$0.00$0.00Stock-based compensation

$0.02$0.02Non-GAAP basic net loss per share

($0.01)($0.01)Non-GAAP diluted net loss per share

($0.01)($0.01)GAAP weighted average shares outstanding used in calculating basic net loss per share

72,113,00761,352,524GAAP weighted average shares outstanding used in calculating diluted net loss per share

72,113,00761,352,524Adjustments for dilutive potential common stock

--Weighted average shares outstanding used in calculating non-GAAP diluted net loss per share

72,113,00761,352,524 

 

 Solta Medical, Inc. CONDENSED CONSOLIDATED BALANCE SHEETS (in thousands of dollars, except share and per share data)(unaudited)March 31,December 31,20132012ASSETSCurrent assets:Cash and cash equivalents 

$26,990$38,097Accounts receivable, net

21,60720,570Inventories

21,25416,611Prepaid expenses
'/>"/>

SOURCE Solta Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Solta Medical to Present at the 25th Annual ROTH Growth Stock Conference on March 18, 2013
2. Solta Medical Reports Fourth Quarter and Full Year 2012 Results
3. Solta Medical to Report Fourth Quarter 2012 Results Release and Host Conference Call on February 19, 2013
4. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
5. Solta Medical to Acquire Sound Surgical Technologies
6. Solta Medical Reports Third Quarter Results
7. Solta Medical And BTL Industries Resolve Patent Dispute
8. Solta Medical to Present at the 32nd Annual Canaccord Growth Conference
9. Solta Medical, Inc. Closes Public Offering of Common Stock
10. Solta Medical, Inc. Prices $15 Million Public Offering of Common Stock
11. Solta Medical, Inc. Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
(Date:1/22/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), ... for cardiovascular disease and overall health is pleased to provide ... and its outlook for 2015 from the CEO, Mr. ... We would like to take this opportunity to share with ...
(Date:1/22/2015)... 22, 2015  Profil Institute for Clinical Research, Inc., a ... announced today a new textbook,  Translational Research Methods for ... a leading global scientific publisher. The textbook ... for use in early phase clinical studies of new ...
Breaking Medicine Technology:BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... Presented at Leading Urology Meeting Show that Simple Urine ... Cancer Detection, Reduce Unnecessary Biopsies -- Gen-Probe to Begin ... Approval -SAN DIEGO, April 29 Eight studies presented ... Urological Association (AUA) suggest that Gen-Probe,s (Nasdaq: ...
... on 11 Patients at SAWCPRINCETON, N.J., April 29 ... (OTC Bulletin Board: DSCI), a provider of advanced wound ... the Advances in Wound Care (SAWC) in Dallas, Jason R. ... Florida, revealed details of a recently concluded 11-patient venous leg ...
Cached Medicine Technology:Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 2Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 3Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 4Investigational Genetic Test May Help Address Common Problems in Prostate Cancer Diagnosis 5Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 2Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R) 3
(Date:1/22/2015)... The U.S. Pharmacopeial Convention is pleased ... Clinical Pharmacy Services at North Carolina State’s College of ... 2015 Beal Award for Distinguished Volunteer Service—the organization’s highest ... the contributions of volunteer experts to direct its work ...
(Date:1/22/2015)... Gabe’s Chemo Duck Program is pleased to announce ... ever created for kids with cancer. The Chemo Duck App, available ... filled with enjoyable games to help children of all ages living ... helps to keep kids entertained, educated and at ease while waiting ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota ... it means to “Live Fearless.” , The “Faces ... their stories about how they or someone they know has ... living in the moment. By telling these types of stories ...
(Date:1/22/2015)... Thousand of GranuFlo lawsuits ( http://www.granuflolawsuit2014.com/ ... GranuFlo and NaturaLyte dialysis concentrates continue to move forward ... Court, District of Massachusetts, Bernstein Liebhard LLP reports. According ... remanded a case filed by the state of Louisiana ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 A ... Sports Medicine flagship journal Medicine & Science in ... before exercise may help reduce gastrointestinal (GI) problems ... , Participants in the double-blind, placebo-controlled study ...
Breaking Medicine News(10 mins):Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 2Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 3Health News:Gigi Davidson, Pioneer in Veterinary Pharmacy and Leader in Pharmacy Compounding, honored with USP’s Beal Award for Dedication to Public Health 4Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3
... up late at night, when hunger strikes may seem a ... because people do // not eat enough throughout the day. ... they tend to crave carbs and sweets . ,Studies ... irritable and angry. When these same people resume normal eating ...
... a recent study researchers offer new insights about stretching. ... Specialists say stretching does not reduce the risk of ... muscles weaker for 10 to 15 minutes and may ... likely causes of injuries include fatigue, overuse, weakness and ...
... risk of breast cancer say researchers based on findings from ... short, but severe decrease in food intake during the 1944-1945 ... women not affected by the famine. ,Approximately 15,000 women ... in the Dutch breast cancer screening program between 1983 and ...
... the leading causes of blindness in the United States. It ... // layer of cells at the back of the eye. ... incidence can be reduced with aggressive control of blood glucose ... age 40 or older, suffer from diabetic retinopathy, and that ...
... animals suggest a potential treatment to minimize disability after ... ,"Our approach is based on a natural mechanism cells ... say specialists . Researchers say the goal of their ... death that occurs in the hours and days after ...
... Two recent studies found to offer good news for ... can reduce depression // in the elderly. Researchers studied ... the participants suffered from major depression, while the other ... adults lived alone and had an annual income of ...
Cached Medicine News:Health News:New Findings Could Reduce The Extent Of Spinal Cord Injuries 2
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 8.0 mm and length 5 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 12 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 11 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm....
Medicine Products: